Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Topical Capsaicin Cream for Stable Angina

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \> or = 3 month history of chronic, stable, angina triggered by physical effort or mental/emotional stress~* documented stress-induced ST depression, reversible perfusion imaging, or wall motion abnormality or CAD \>50%~* Canadian Cardiovascular (CV) Class I-III~* Receiving medical therapy for \> or = 2 months~* Ability to perform Bruce Protocol treadmill test~* non-pregnant female~Exclusion Criteria:~* unstable angina~* revasc within 2 months~* Myocardial infarction (MI) within 2 months~* congestive heart failure (CHF) hospitalization within 2 months~* New York Heart Association (NYHA) class III or IV~* left ventricular ejection fraction (LVEF) \< 25%~* abnormal ECG; Acute changes on ECG~* Currently receiving treatment with investigational drugs/devices~* Uncontrolled hypertension~* contraindication to exercise stress testing~* allergy to red peppers or capsaicin~* skin deformity, scar, or rash at application site~* abdominal surgery within 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 0.1% Capsaicin Cream (Type: ACTIVE_COMPARATOR): 0.1% capsaicin cream spread 8cm x 15cm on abdomen, once, 45 minutes prior to exercise
- Placebo Cream (Type: PLACEBO_COMPARATOR): Inactive cream, 4cm spread 8cm x 15cm on the abdomen, once, 45 minutes prior to exercise

Based on this trial design, predict the completion outcome and termination type (if applicable).